AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Targetby Mark Eisenberg 22.06.2024AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
Monero Slides Over 4% in 24 Hours, Market Cap at $2.98Bby John Darbie 21.06.2024Monero's XMR price drops 4.47% in 24 hours to $162.05, continuing a week's negative trend. Trading volume tumbles 39%, market ...
Ashtead Technology Shares Dip 0.4% Amid Dividend Increaseby Lilu Anderson 21.06.2024Ashtead Technology (LON:AT) shares dip 0.4%; company announces higher dividend, strong financials, positive analyst outlook, and notable insider trades.
SoftBank CEO Eyes AI Superiority; Needs Partners, Huge Fundsby Mark Eisenberg 21.06.2024SoftBank CEO Masayoshi Son plans to create AI super intelligence 10,000 times more capable than humans, focusing on robotics and ...
The Graph’s GRT Surges 4% in 24 Hours, Hits $2.15B Market Capby John Darbie 20.06.2024The Graph's (GRT) price surges 4.38% to $0.23 in 24 hours despite recent losses. Market cap at $2.15B, ranked #50 ...
Top 3 Reasons To Invest in Ethereum: Insights from Bitwise CIOby John Darbie 20.06.2024Discover why Bitwise CIO Matt Hougan recommends adding Ethereum to your portfolio for diversification, varied use cases, and boosted returns.
Ethereum At A Crossroads: Big Move After Consolidation?by John Darbie 20.06.2024Ethereum at a crucial point as it enters a consolidation phase; traders eye potential volatility. Will ETH break out or ...
Fortress Biotech Sees Upgrades Amid Investor Shiftsby Lilu Anderson 20.06.2024"Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
Ethereum’s Price Surge: Whale Activity Sparks Hope, Risks Persistby John Darbie 20.06.2024"Ethereum rebounds to $3,527, buoyed by strong whale activity and breaking key resistance levels, but faces potential market and regulatory ...
Expensify CEO Sells $73K in Shares Amid Revenue Surgeby Mark Eisenberg 20.06.2024Expensify CEO David Barrett sells over $73K in shares amid strategic business moves; investors eye impacts on company’s financial stability.